Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Kyung-Yeon | - |
dc.contributor.author | Oh, Euichaul | - |
dc.contributor.author | Kwak, Mi-Kyoung | - |
dc.contributor.author | Jun, Hyun Sik | - |
dc.contributor.author | Heo, Tae-Hwe | - |
dc.date.accessioned | 2021-09-04T01:47:25Z | - |
dc.date.available | 2021-09-04T01:47:25Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-03-07 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89231 | - |
dc.description.abstract | Pravastatin is a lipid-lowering agent that attenuates atherosclerosis. However, the multifactorial pathogenesis of atherosclerosis requires other drugs with different anti-atherogenic mechanisms. We chose sarpogrelate as an anti-platelet agent and a novel component of a complex drug with pravastatin due to its high potential but little information on its beneficial effects on atherosclerosis. Low-density lipoprotein receptor-knockout mice were fed a highfat, high-cholesterol diet and treated with pravastatin alone, sarpogrelate alone, or a combination of both drugs. Although sarpogrelate alone did not significantly reduce atherosclerotic plaque areas, co-treatment with pravastatin significantly decreased aortic lesions compared to those of the pravastatin alone treated group. The combined therapy was markedly more effective than that of the single therapies in terms of foam cell formation, smooth muscle cell proliferation, and inflammatory cytokine levels. These results suggest that pravastatin and sarpogrelate combined therapy may provide a new therapeutic strategy for treating atherosclerosis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.subject | AORTIC ATHEROSCLEROSIS | - |
dc.subject | PROGRESSION | - |
dc.subject | MODULATION | - |
dc.subject | RABBITS | - |
dc.subject | DISEASE | - |
dc.title | Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jun, Hyun Sik | - |
dc.identifier.doi | 10.1371/journal.pone.0150791 | - |
dc.identifier.scopusid | 2-s2.0-84962206780 | - |
dc.identifier.wosid | 000371990100062 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.11, no.3 | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 11 | - |
dc.citation.number | 3 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | AORTIC ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | MODULATION | - |
dc.subject.keywordPlus | RABBITS | - |
dc.subject.keywordPlus | DISEASE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.